The role of the pineal gland and melatonin in the regulation of adenohypophysial hormone synthesis and secretion;Rola szyszynki oraz melatoniny w regulacji syntezy i wydzielania wybranych hormonów częs̈ci gruczołowej przysadki

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 653-659

  Juszczak, Marlena ^a   Michalska, Monika ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adrenocorticotrophin; Melatonin; Pineal gland; Somatotrophin; Thyreotrophin

Indexed keywords

ADENOHYPOPHYSIS HORMONE; MELATONIN; NEUROPEPTIDE; PINEAL PEPTIDE E5; UNCLASSIFIED DRUG;

ANIMAL; BIOSYNTHESIS; HUMAN; PHYSIOLOGY; REVIEW; SECRETION;

ANIMALS; HUMANS; MELATONIN; NEUROPEPTIDES; PITUITARY HORMONES, ANTERIOR;

EID: 33847044105     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Acuna D., Garcia del Rio C., Garcia-Torres L., Luna J., Osorio C.: Role of pineal gland in kidney-adrenal homeostasis. Horm. Metab. Res., 1984; 16: 589-592
2. Baltaci A.K., Mogulkoc R., Bediz C.S., Kul A., Ugur A.: Pinealectomy and zinc deficiency have opposite effects on thyroid hormones in rats. Endocrine Res., 2003; 4: 473-481
3. Baltaci A.K., Mogulkoc R., Kul A., Bediz C.S., Ugur A.: Opposite effects of zinc and melatonin on thyroid hormones in rats. Toxicology, 2004; 195: 69-75
4. Beck-Friis J., Ljunggren J.G., Thoren M., von Rosen D., Kjellman B.F., Wetterberg L.: Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroe ndocrinology, 1985; 10: 173-186
5. Bellastella A., Pisano G., Iorio S., Pasquali D., Orio F., Venditto T., Sinisi A.A.: Endocrine secretions under abnormal light-dark cycles and in the blind. Horm. Res., 1998; 49: 153-157
6. Bellastella A., Sinisi A.A., Criscuolo T., De Bellis A., Carella C., Iorio S., Sinisi A.M., Parlato F., Venditto T., Pisano G.: Melatonin and the pituitary-thyroid axis status in blind adults: A possible resetting after puberty. Clin. Endocrinol., 1995; 43: 707-711
7. Bockmann J., Böckers T.M., Vennemann B., Niklowitz P., Müller J., Wittkowski W., Sabel B., Kreutz M.R.: Short photoperiod-dependent down-regulation of thyreotropin-alpha and-beta in hamster pars tuberalis-specific cells is prevented by pinealectomy. Endocrinology, 1996; 137: 1804-1813
8. Böckers T.M., Niklowitz P., Bockmann J., Fauteck J.D., Wittkowski W., Kreutz M.R.: Daily melatonin injections induce cytological changes in pars tuberalis-specific cells similar to short photoperiod. J. Neuroendocrinol., 1995; 7: 607-613
9. Brammer G.L., Morley J.E., Geller E., Yuwiler A., Hershman J.M.: Hypothalamus-pituitary-thyroid axis interactions with pineal gland in the rat. Am. J. Physiol., 1979; 236: E416-E420
10. Brismar K., Werner S., Thoren M., Wetterberg L.: Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion. J. Endocrinol. Invest., 1985; 8: 91-95
11. Chamberlain R.S., Herman B.H.: A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides and serotonin in autism. Biol. Psychiatry, 1990; 28: 773-793
12. Coiro V., Vescovi P.P.: Alcoholism abolishes the effects of melatonin on growth hormone secretion in humans. Neuropeptides, 1998; 32: 211-214
13. Dardente H., Klosen P., Pévet P., Masson-Pévet M.: MT1 melatonin receptor mRNA expressing cells in pars tuberalis of the European hamster: effect of photoperiod. J. Neuroendocrinol., 2003; 15: 778-786
14. Demisch L., Demisch K., Nickelsen T.: Influence of dexametasone on nocturnal melatonin production on healthy adult subjects. J. Pineal Res., 1988; 5: 317-322
15. Diaz Rodriguez E., Fernandez Alvarez C., Castrillon P.O., Esquifino Parras A.I., Diaz Lopez B.: In vitro pituitary prolactin, growth hormone and follicle stimulating hormone secretion during sexual maturation of female rats primed with melatonin. Acta Neurobiol. Exp., 2001; 61: 27-33
16. Esposti D., Lissoni P., Mauri R., Rovelli F., Orsenigo L., Pescia S., Vegetti G., Esposti G., Fraschini F.: The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man. J. Endocrinol. Invest., 1988; 11: 103-106
17. Esquifino A., Agrasal C., Velázquez E., Villanua M.A., Cardinali D.P.: Effect of melatonin on serum cholesterol and phospholipid levels and on prolactin, thyroid-stimulating hormone and thyroid hormone levels, in hyperprolactinemic rats. Life Sci., 1997; 61: 1051-1058
18. Ferrari E., Magri F., Dori D., Migliorati G., Nescis T., Molla G., Fioravanti M., Solerte S.B.: Neuroendocrine correlates of the aging brain in humans. Neuroendocrinology, 1995; 61: 464-470
19. Filippa V., Mohamed F.: ACTH cells of pituitary pars distalis of viscacha (Lagostomus maximus maximus): immunohistochemical study in relation to season, sex, and growth. Gen. Comp. Endocrinol., 2006; 146: 217-225
20. Fischer S., Smolnik R., Herms M., Born J., Fehm H.L.: Melatonin acutely improves the neuroendocrine architecture of sleep in blind individuals. J. Clin. Endocrinol. Metab., 2003; 88: 5315-5320
21. Fornas O., Mato M.E., Webb S.M.: Antiproliferative effect and cell cycle modulation by melatonin on GH3 cells. Horm. Res., 2000; 53: 251-255
22. Gauer F., Masson-Pévet M., Skene D.J., Vivien-Roels B., Pévet P.: Daily rhythms of melatonin binding sites in the rat pars tuberalis and surachiasmatic nuclei; evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology, 1993; 57: 120-126
23. Gordon J., Morley J.E., Hershman J.M.: Melatonin and the thyroid. Horm. Metab. Res., 1980; 12: 71-73
24. Gupta D.: The pineal gland in relation to growth and development in children. J. Neural Transm. Suppl., 1986; 21: 217-232
25. Hira Y., Sakai Y., Matsushima S.: Effects of photoperiod and melatonin on the development of growth hormone cells and the pituitaryadrenal axis in the Djungarian hamster, Phodopus sungorus. Arch. Histol. Cytol., 2001; 64: 211-222
26. John T.M., Viswanathan M., George J.C., Scanes C.G.: Influence of chronic melatonin implantation on circulating levels of catecholamines, growth hormone, thyroid hormone, glucose, and free fatty acids in the pigeon. Gen. Comp. Endocrinol., 1990; 79: 226-232
27. Juszczak M.: Melatonin affects the oxytocin and prolactin responses to stress in male rats. J. Physiol. Pharmacol., 1998; 49: 151-163
28. Juszczak M.: Udział szyszynki oraz melatoniny w regulacji syntezy i uwalniania hormonów częs̈ci nerwowej przysadki. Endokrynologia Polska, 2004; 55: 206-210
29. Juszczak M., Michalska M.: Wpływ melatoniny na syntezę i wydzielanie prolaktyny, hormonu luteinizującego (LH) i folikulotropowego (FSH). Post. Hig. Med. Dos̈w., 2006; 60: 431-438
30. Karasek M.: Szyszynka i melatonina. Wydawnictwo Naukowe PWN, Warszawa-Łódź, 1997
31. Kasuya E., Kushibiki S., Sutoh M., Saito T., Ito S., Yayou K., Sakumoto R., Hodate K.: Effect of melatonin injected into the third ventricle on growth hormone secretion in Holstein steers. J. Vet. Med. Sci., 2006; 68: 1075-1080
32. Kellner M., Yassouridis A., Manz B., Steiger A., Holsboer F., Wiedemann K.: Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers-A potential link to low-melatonin syndrome in depression? Neuroendocrinology, 1997; 65: 284-290
33. Klosen P., Bienvenu C., Demarteau O., Dardente H., Guerrero H., Pévet P., Masson-Pévet M.: The mt1 melatonin receptor and RORbeta receptor are co-localized in specific TSH-immunoreactive cells in the pars tuberalis of the rat pituitary. J. Histochem. Cytochem., 2002; 50: 1647-1657
34. Konakchieva R., Mitev Y., Almeida O.F., Patchev V.K.: Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release. Biol. Cell., 1997; 89: 587-596
35. Konakchieva R., Mitev Y., Almeida O.F., Patchev V.K.: Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology, 1998; 67: 171-180
36. Kostoglou-Athanassiou I., Treacher D.F., Wheeler M.J., Forsling M.L.: Melatonin administration and pituitary hormone secretion. Clin. Endocrinol., 1998; 48: 31-37
37. Kostoglou-Athanassiou I., Treacher D.F., Wheeler M.J., Forsling M.L.: Bright light exposure and pituitary hormone secretion. Clin. Endocrinol., 1998; 48: 73-79
38. Lerner A.B., Case J.D., Heinzelman R.U.: Structure of melatonin. J. Am. Chem. Soc. 1959; 81: 6084-6085
39. Lerner A.B., Case J.D., Takahashi Y., Lee T.H., Mori N.: Isolation of melatonin, pineal factor that lightens melanocytes. J. Am. Chem. Soc., 1958; 80: 2587
40. Lissoni P., Resentini M., Mauri R., de Medici C., Morabito F., Esposti D., Di Bella L., Esposti G., Rossi D., Parravicini L., et al.: Effect of an acute injection of melatonin on the basal secretion of hypophyseal hormones in prepubertal and pubertal healthy subjects. Acta Endocrinol., 1986; 111: 305-311
41. Meeking D.R., Wallace J.D., Cuneo R.C., Forsling M., Russell-Jones D.L.: Exercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy adult male subjects. Eur. J. Endocrinol., 1999; 141: 22-26
42. Mero A.A., Vahalummukka M., Hulmi J.J., Kallio P., von Wright A.: Effects of resistance exercise after oral ingestion of melatonin on physiological and performance responses of adult men. Eur. J. Appl. Physiol., 2006; 96: 729-739
43. Milin J., Demajo M., Todoroviæ V.: Rat pinealocyte reactive response to a long-term stress inducement. Neuroscience, 1996; 3: 845-854
44. Mirunalini S., Subramanian P.: Temporal oscillations of thyroid hormones in long term melatonin treated rats. Pharmazie, 2005; 60: 52-56
45. Morgan P.J., Barrett P., Howell E., Helliwell R.: Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int., 1994; 24: 101-146
46. Ninomiya T., Iwatani N., Tomoda A., Miike T.: Effects of exogenous melatonin on pituitary hormones in humans. Clin. Physiol., 2001; 21: 292-299
47. Ostrowska Z., Kos-Kudla B., Swiêtochowska E., Marek B., Kajdaniuk D., Ciesielska-Kopacz N.: Influence of pinealectomy and long-term melatonin administration on GH-IGF-I axis function in male rats. Neuro Endocrinol. Lett., 2001; 22: 255-262
48. Ozturk G., Coskun S., Erbas D., Hasanoglu E.: The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn. J. Physiol., 2000; 50: 149-153
49. Reiter R.J.: The pineal and its hormone in control of reproduction in mammals. Endocrine Rev., 1980; 1: 109-131
50. Reiter R.J.: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev., 1991; 12: 151-180
51. Reiter R.J., Oh C.S., Fujimori O.: Melatonin: its intracellular and genomic actions. Trends Endocrinol. Metab., 1996; 7: 22-27
52. Relkin R.: Effects of pinealectomy, constant light and darkness on growth hormone levels in the pituitary and plasma of the rat. J. Endocrinol., 1972; 53: 289-293
53. Relkin R.: Use of melatonin and synthetic TRH to determine site of pineal inhibition of TSH secretion. Neuroendocrinology, 1978; 25: 310-318
54. Richardson S.B., Hollander C.S., Prasad J.A., Hirooka Y.: Somatostatin release from rat hypothalamus in vitro: effects of melatonin and serotonin. Endocrinology, 1981; 109: 602-606
55. Sakamoto S., Nakamura K., Inoue K., Sakai T.: Melatonin stimulates thyroid-stimulating hormone accumulation in the thyreotropes of the rat pars tuberalis. Histochem. Cell Biol., 2000; 114: 213-218
56. Shibui K., Uchiyama M., Okawa M., Kudo Y., Kim K., Liu X., Kamei Y., Hayakawa T., Akamatsu T., Ohta K., Ishibashi K.: Diurnal fluctuation of sleep propensity and hormonal secretion across the menstrual cycle. Biol. Psychiatry, 2000; 48: 1062-1068
57. Siegrist C., Benedetti C., Orlando A., Beltran J.M., Tuchscherr L., Noseda C.M., Brusco L.I., Cardinali D.P.: Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleepdisturbed, middle-aged, and elderly patients. J. Pineal Res., 2001; 30: 34-42
58. Smythe G.A., Lazarus L.: Growth hormone regulation by melatonin and serotonin. Nature, 1973; 244: 230-231
59. Sorrentino S.Jr., Reiter R.J., Schalch D.S.: Pineal regulation of growth hormone synthesis and release in blinded and blinded-anosmic male rats. Neuroendocrinology, 1971; 7: 210-218
60. Soszyñski P., Zgliczyñski S., Pucilowska J.: The circadian rhythm of melatonin in hypothyroidism and hyperthyroidism. Acta Endocrinol., 1988; 119: 240-244
61. Szafarczyk A., Pelzer E., Ixart G., Malaval F., Nouguier-Soulé J., Assenmacher I.: Persistence of circadian rhythms of plasma ACTH and corticosterone after pinealectomy in sighted or blind rats. C. R. Seances Acad. Sci. III, 1983; 297: 471-476
62. Terzolo M., Piovesan A., Puligheddu B., Torta M., Osella G., Paccotti P., Angeli A.: Effects of long-term, low-dose, time-specified melatonin administration on endocrine and cardiovascular variables in adult men. J. Pineal Res., 1990; 9: 113-124
63. Terzolo M., Revelli A., Guidetti D., Piovesan A., Cassoni P., Paccotti P., Angeli A., Massobrio M.: Evening administration of melatonin enhances the pulsatile secretion of prolactin but not of LH and TSH in normally cycling women. Clin. Endocrinol., 1993; 39: 185-191
64. Valcavi R., Dieguez C., Azzarito C., Edwards C.A., Dotti C., Page M.D., Portioli I., Scanlon M.F.: Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjects. Clin. Endocrinol., 1987; 26: 453-458
65. Valcavi R., Zini M., Maestroni G.J., Conti A., Portioli I.: Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone. Clin. Endocrinol., 1993; 39: 193-199
66. Vriend J.: Evidence for pineal gland modulation of the neuroendocrine-thyroid axis. Neuroendocinology, 1983; 36: 68-78
67. Vriend J., Sheppard M.S., Borer K.T.: Melatonin increases serum growth hormone and insulin-like growth factor I (IGF-I) levels in male Syrian hamsters via hypothalamic neurotransmitters. Growth Dev. Aging, 1990; 54: 165-171
68. Walker A.B., English J., Arendt J., MacFarlane I.A.: Hypogonadotrophic hypogonadism and primary amenorrhoea associated with increased melatonin secretion from a cystic pineal lesion. Clin. Endocrinol., 1996; 45: 353-356
69. Weidenfeld Y., Schmidt U., Nir I.: The effect of exogenous melatonin on the hypothalamic-pituitary-adrenal axis in intact and pinealectomized rats under basal and stressed conditions. J. Pineal Res., 1993; 14: 60-66
70. Wright J., Aldhous M., Franey C., English J., Arendt J.: The effects of exogenous melatonin on endocrine function in man. Clin. Endocrinol., 1986; 24: 375-382
71. Wu Y.H., Zhou J.N., Balesar R., Unmehopa U., Bao A., Jockers R., Van Heerikhuize J., Swaab D.F.: Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J. Comp. Neurol., 2006; 499: 897-910
72. Yasin S.A., Costa A., Besser G.M., Hucks D., Grossman A., Forsling M.L.: Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology, 1993; 132: 1329-1336
73. Yu C.X., Wu G.C., Xu S.F., Chen C.H.: Effect of melatonin on proopiomelanocortin mRNA expression in arcuate nucleus of rat hypothalamus. Acta Pharmacol. Sin., 2000; 21: 421-424
74. Zeman M., Buyse J., Lamosova D., Herichova I., Decuypere E.: Role of melatonin in the control of growth and growth hormone secretion in poultry. Domest. Anim. Endocrinol., 1999; 17: 199-207